Company: GANX
Filing Date: 2025-04-17
Form Type: PRE 14A
Source: 0001558370-25-004958
Chunk: 38

Company: Gain Therapeutics, Inc.
Filing Date: 2025-04-17
Form: PRE 14A
Chunk 38
---
 ​ |   204,488 | ​ |   227,209 | ​ |
| Matthias Alder(3)     |   |   262,500 | ​ |       N/A | ​ |
| C. Evan Ballantyne(4) |   |    58,333 | ​ |       N/A | ​ |

| (1) | Mr. Mack served as our Chief Financial Officer from April 8, 2024 to January 6, 2025. From June 25, 2024 to January 7, 2025, Mr. Mack also served as our Interim Chief Executive Officer, a role for which he received no additional compensation. He was appointed as our permanent Chief Executive Officer on January 6, 2025. |

| (2) | Mr. Fuggetta was appointed our Senior Vice President Finance and Principal Financial Officer effective January 6, 2025. Mr. Fuggetta’s base salary has been converted from Swiss francs into U.S. dollars at the 2024 average exchange rate of $1.136. |

| (3) | Mr. Alder was appointed as our Chief Executive Officer effective September 20, 2022 and served as our Chief Executive Officer until June 25, 2024. |

| (4) | Mr. Ballantyne was appointed as our Chief Financial Officer effective April 10, 2023 and served as our Chief Financial Officer until March 1, 2024. |

Non-Equity Incentive Plan Compensation In accordance with the terms of their respective employment agreements, our named executive officers are eligible to receive discretionary annual bonuses of up to a percentage of each executive’s gross base salary based on individual

performance, company performance or as otherwise determined appropriate, as determined by the Compensation Committee.

| ​                    | ​ |          ​ | ​ |          ​ |
| ​                    |   | 2024 Bonus |   | 2025 Bonus |
| ​                    | ​ |     Target | ​ |     Target |
| Name                 | ​ |         -% | ​ |         -% |
| Gene Mack(1)         |   |         35 |   |         50 |
| Gianluca Fuggetta(2) | ​ |          — | ​ |         30 |
| Matthias Alder(3)    |   |         50 |   |          — |
| Evan Ballantyne(4)   |   |